Fighting cancer is hard enough, but paying for the treatments can be overwhelming. Cancer drugs are treated differently than other types of drugs for several
The cost of a new drug treatment has soared into the stratosphere, dramatically impacting consumers. These findings came out of a recent study by researchers
A recent story at CBSNews highlighted a disturbing new trend – massive layoffs among top tech companies. Whether this is tied to the predicted recession,
The pharmacy benefits landscape may be shifting with the new Federal Trade Commission appointee Alvaro Bedoya. He should be the tie-breaker in the 2-2 gridlock that has plagued the commission. One of the stymied issues has been whether the FTC should move forward in its investigation into the cost of insulin.
Austin Business Journal “Best Places to Work” contest names RazorMetrics as a winner AUSTIN, Texas, May 31, 2022 /PRNewswire/ — RazorMetrics, an Austin-based drug cost reduction platform, has
As with medicine today one of the major and newer technologies is robotic surgery and robotic assist. Surgical robots, such as the da Vinci surgical system, allow surgeons to perform with greater precision and require smaller incisions. In a robotic surgery, the surgeon controls robotic arms with a remote manipulator or a computer. Common robot-assisted surgeries include prostate cancer tumor removal and bariatric surgery.
AUSTIN, Texas, April 26, 2022/PRNewswire/ – Castlight Health is the newest member of RazorMetrics’ Partnership Collective, and RazorMetrics is joining Castlight’s Ecosystem of leading digital health companies. Castlight, a connected health navigation company, offers a world-class digital platform with a team of clinical and benefits experts who help members easily connect with the right programs and care at the right time, delivering better health outcomes and helping to maximize returns on healthcare investments.
RazorMetrics, an innovative healthcare technology company, recently conducted a consumer opinion survey asking about drug costs and found some surprising results. Despite the explosion in consumer-oriented drug savings options – mail-order pharmacy, discount cards, etc. – healthcare consumers want their physician to take the lead on lowering drug costs. The survey found that 80% of respondents would prefer their physician be the one to choose a lower-cost drug for their prescription and do so automatically.
Last week, Pfizer voluntarily recalled three of their hypertension drugs, including Accuretic, due to nitrosamine levels in the medication. Nitrosamine is common and safe in low amounts, but the drug pushed people above the acceptable daily intake limit, which increased the risk of cancer down the road.
In a recent article in Yahoo Finance, ‘As President Biden eyes drug pricing, expert laments ‘failure of democracy’. The article states that 25% of Americans can’t afford their prescriptions and one-third have skipped a prescription due to cost.
And, we are waiting…
Contact us, and we will be more than happy to answer all of your questions.
